Kamel Besseghir

Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland.

Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.

Oncodesign SA is a biopharmaceutical company, which engages in the provision of solutions for the assessment and validation of anti-cancer therapies. It also offers services in pharmacology, pharmco-imaging, bio-analysis, bio-banking, translational bio-makers, and bio-decontamination. The firm operates through the following business units: Service, Biotech, and Artificial Intelligence. The company was founded by Philippe Genne and Eric Solary on January 17, 1995 and is headquartered in Dijon, France.